| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/11/2013 | US8461106 Biofilm prevention using lactoferrin |
| 06/11/2013 | US8461105 Polymer-based sustained release device |
| 06/11/2013 | US8461104 Surface protection of exposed biological tissues |
| 06/11/2013 | US8460927 B7-H1 antibodies and method of use |
| 06/11/2013 | US8460894 Calcium-sensing receptor 2 (CaR2) and methods for using |
| 06/11/2013 | US8460882 Cancer biomarkers |
| 06/11/2013 | US8460713 Administration of cells and cellular extracts for rejuvenation |
| 06/11/2013 | US8460709 Pharmaceutical microparticles |
| 06/11/2013 | US8460706 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 06/11/2013 | US8460697 Pro-angiogenic peptides and uses thereof |
| 06/11/2013 | US8460694 Solvent/polymer solutions as suspension vehicles |
| 06/11/2013 | US8460683 Protein or glycoprotein from Haliotis midae and its use as an immunotherapy agent |
| 06/11/2013 | US8460676 Composition comprising VLP and amyloid beta peptide |
| 06/11/2013 | US8460675 Viral chemokine-antigen fusion proteins |
| 06/11/2013 | US8460656 Phytase variants |
| 06/11/2013 | US8460655 Pharmacological vitreolysis |
| 06/11/2013 | US8460654 Use of alkaline phosphatase to maintain healthy tissue mass in mammals |
| 06/11/2013 | US8460653 Superoxide dismutase variants and methods of use thereof |
| 06/11/2013 | US8460652 Topical skin care formulations |
| 06/11/2013 | CA2643508C Process for obtaining high efficiency human albumin for use in detoxification therapy |
| 06/11/2013 | CA2567795C Methods of treating type i diabetes by blocking vegf-mediated activity |
| 06/11/2013 | CA2533512C Antagonists and agonists of ldcam and methods of use |
| 06/11/2013 | CA2513388C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2467927C Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/11/2013 | CA2448835C Use of follistatin to increase muscle mass |
| 06/11/2013 | CA2437942C Chimeric molecules to modulate gene expression |
| 06/11/2013 | CA2437064C Storage-stable, liquid fibrinogen formulation |
| 06/11/2013 | CA2436832C Crystal form of a cyclic depsipeptide having improved activity |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/11/2013 | CA2426012C Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 06/11/2013 | CA2407959C Human wingless-like gene |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 06/11/2013 | CA2400410C Antimicrobial compounds and formulations |
| 06/11/2013 | CA2377381C Neovascular-targeted immunoconjugates |
| 06/11/2013 | CA2312826C Hemiasterlin analogs |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/11/2013 | CA2229307C Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 06/07/2013 | CA2761253A1 Combinations of therapeutic agents for treating melanoma |
| 06/06/2013 | WO2013082563A1 Protein inhibitors to complement and vegf pathways and methods of use thereof |
| 06/06/2013 | WO2013082543A1 Mesenchymal stromal cells and uses related thereto |
| 06/06/2013 | WO2013082535A2 Controlled-release peptide compositions and uses thereof |
| 06/06/2013 | WO2013082531A2 Broad spectrum influenza a neutralizing vaccines and d-peptidic compounds, and methods for making and using the same |
| 06/06/2013 | WO2013082472A1 Methods and products for treating preeclampsia and modulating blood pressure |
| 06/06/2013 | WO2013082449A2 Treatment of b cell lymphomas |
| 06/06/2013 | WO2013082427A1 Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same |
| 06/06/2013 | WO2013082292A1 A method to enhance cognition |
| 06/06/2013 | WO2013082286A1 Peptide-mediated delivery of active agents across the blood-brain barrier |
| 06/06/2013 | WO2013082254A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| 06/06/2013 | WO2013082116A1 Therapeutic agents comprising insulin amino acid sequences |
| 06/06/2013 | WO2013082114A1 Use of p3 of bacteriophage as amyloid binding agents |
| 06/06/2013 | WO2013082045A1 Netrin loop peptide mimetics and uses thereof |
| 06/06/2013 | WO2013082017A1 Cyclized peptidomimetic small molecule inhibitors of the wdr5 and mll1 interaction |
| 06/06/2013 | WO2013081091A1 Drug for producing radiolabeled polypeptide reducing non-specific renal accumulation |
| 06/06/2013 | WO2013080207A1 Treatment of spinal cord injury with resolving phenotype macrophages or with mmp-13 |
| 06/06/2013 | WO2013080167A1 Compounds for the treatment of tuberculosis |
| 06/06/2013 | WO2013080153A1 Inotropic compounds |
| 06/06/2013 | WO2013079691A1 Insulin glargine versus metformin for the first-line treatment of early type 2 diabetes |
| 06/06/2013 | WO2013079487A1 Pharmaceutical composition for use in the treatment of dysfunction associated with aging |
| 06/06/2013 | WO2013079373A1 Collagen hydrolysate and use thereof |
| 06/06/2013 | WO2013079213A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome |
| 06/06/2013 | WO2013024040A3 Tnf superfamily trimerization inhibitors |
| 06/06/2013 | WO2013012771A3 Clinical applications of a recombinant human endostatin adenovirus (e10a) injection |
| 06/06/2013 | WO2012177903A4 Methods of treating cognitive impairment |
| 06/06/2013 | WO2012101601A9 Glycogen synthase kinase-3 inhibitors |
| 06/06/2013 | WO2012101599A9 Glycogen synthase kinase-3 inhibitors |
| 06/06/2013 | US20130144043 Polysialic acid derivatives |
| 06/06/2013 | US20130144042 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/06/2013 | US20130144036 Quinoxaline-containing compounds as hepatitis c virus inhibitors |
| 06/06/2013 | US20130144014 Multi-arm block copolymers as drug delivery vehicles |
| 06/06/2013 | US20130143955 Cyclic di-GMP-II Riboswitches, Motifs, and Compounds, and Methods for Their Use |
| 06/06/2013 | US20130143953 Compositions, kits and methods for treatment of complement-related disorders |
| 06/06/2013 | US20130143943 Modulation of glucocorticoid receptor expression |
| 06/06/2013 | US20130143825 Compounds for use in the treatment of diseases based on the expression of toxic transcripts |
| 06/06/2013 | US20130143824 Compositions and methods for enhancing apoptosis |
| 06/06/2013 | US20130143823 Compositions and methods of inhibiting apoptosis |
| 06/06/2013 | US20130143821 Hydrophobically-modified hyaluronan and methods of making and using thereof |
| 06/06/2013 | US20130143820 Diuretic and natriuretic polypeptides |
| 06/06/2013 | US20130143819 Ferrimannitol-ovalbumin tablet composition |
| 06/06/2013 | US20130143818 Factor VIII Glycoforms |
| 06/06/2013 | US20130143817 Use of transferrin in treatment of beta-thalassemias |
| 06/06/2013 | US20130143814 Protein Therapy for Treatment of Eye Diseases |
| 06/06/2013 | US20130143813 Methods and compositions for modulating hgf/met |
| 06/06/2013 | US20130143811 Tumor Suppression Compositions |
| 06/06/2013 | US20130143808 Fibrin Gel for Controlled Release of PDGF and Uses Thereof |
| 06/06/2013 | US20130143807 Concentrated Protein Preparations of Bone Morphogenetic Proteins and Methods of Use Thereof |
| 06/06/2013 | US20130143805 Ggf2 and methods of use |
| 06/06/2013 | US20130143803 Process for the Preparation of Insulin-Zinc Complexes |
| 06/06/2013 | US20130143802 Fusion peptide therapeutic compositions |
| 06/06/2013 | US20130143801 Methods and compositions for delivering peptides |
| 06/06/2013 | US20130143800 Combination therapies to treat diabetes |
| 06/06/2013 | US20130143799 Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| 06/06/2013 | US20130143797 Glycoproteins Having Lipid Mobilizing Properties an Therapeutic Uses Thereof |
| 06/06/2013 | US20130143795 Method of treatment of hiv or aids |
| 06/06/2013 | US20130143793 Peptide conjugates of glp-1 receptor agonists and gastrin and their use |
| 06/06/2013 | US20130143792 Use of CHEC Peptides to Treat Neurological and Cardiovascular Diseases and Disorders |
| 06/06/2013 | US20130143320 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 06/06/2013 | US20130143316 Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer |
| 06/06/2013 | US20130143294 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |